The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

BOVALTO RESPI INTRANASAL, nasal spray, lyophilisate and solvent for suspension

Boehringer Ingelheim Vetmedica GmbHVPA10454/029/003

Main Information

Trade NameBOVALTO RESPI INTRANASAL, nasal spray, lyophilisate and solvent for suspension
Active SubstancesBovine respiratory syncytial virus, live
Bovine parainfluenza virus 3 attenuated
Dosage FormNasal spray, lyophilisate and solvent for suspension
Licence HolderBoehringer Ingelheim Vetmedica GmbH
Licence NumberVPA10454/029/003

Group Information

ATC CodeQI02AD07 bovine respiratory syncytial virus + bovine parainfluenza virus
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued13/04/2018
Legal StatusPOM (E): Prescription Only Exempt as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back